Adrian Stecyk is the founder of Myrtelle. Myrtelle has raised $43M in total funding. Latest round: Series B. Backed by Kleiner Perkins.
Adrian Stecyk is the co-founder and Chief Executive Officer of Myrtelle, a gene therapy company focused on treating rare monogenetic disorders. He assumed the CEO role in March 2024. Prior to Myrtelle, Stecyk co-founded several other gene therapy companies, including Agilis Biotherapeutics, which was acquired by PTC. He also co-founded Griffin Securities, an investment bank for emerging biotechnology.
Full founder directory · Investor directory · Company funding database · Fundraising library